...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: This so called “Expert Market”

fouremm,  your opinions of DM and lack of management skill and business development are bang on. The fact that a respected company like Cencora just sined  a collaboration deal with Zenith  does speak volumes of Zenith's potential in many respects especially with 12 ongoing trials . I just hope that Dr Sanjay Lakhotia is the one in charge of looking for potential BP deals and partnerships not DM

Share
New Message
Please login to post a reply